These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 35596627)
1. Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2. Hamdy R; Mostafa A; Abo Shama NM; Soliman SSM; Fayed B Phytother Res; 2022 Jul; 36(7):2921-2939. PubMed ID: 35596627 [TBL] [Abstract][Full Text] [Related]
2. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach. Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539 [TBL] [Abstract][Full Text] [Related]
3. Silibinin as potential tool against SARS-Cov-2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects. Speciale A; Muscarà C; Molonia MS; Cimino F; Saija A; Giofrè SV Phytother Res; 2021 Aug; 35(8):4616-4625. PubMed ID: 33822421 [TBL] [Abstract][Full Text] [Related]
4. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein. Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172 [TBL] [Abstract][Full Text] [Related]
5. Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach. Indu P; Rameshkumar MR; Arunagirinathan N; Al-Dhabi NA; Valan Arasu M; Ignacimuthu S J Infect Public Health; 2020 Dec; 13(12):1856-1861. PubMed ID: 33168456 [TBL] [Abstract][Full Text] [Related]
6. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host. Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744 [TBL] [Abstract][Full Text] [Related]
7. Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an Ogunyemi OM; Gyebi GA; Elfiky AA; Afolabi SO; Ogunro OB; Adegunloye AP; Ibrahim IM Antivir Chem Chemother; 2020; 28():2040206620984076. PubMed ID: 33372806 [TBL] [Abstract][Full Text] [Related]
8. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation. Gorla US; Rao K; Kulandaivelu US; Alavala RR; Panda SP Comb Chem High Throughput Screen; 2021; 24(6):879-890. PubMed ID: 32819226 [TBL] [Abstract][Full Text] [Related]
9. Silybin B and Cianidanol Inhibit M Srivastava R; Tripathi S; Unni S; Hussain A; Haque S; Dasgupta N; Singh V; Mishra BN Curr Pharm Des; 2021; 27(32):3476-3489. PubMed ID: 33302853 [TBL] [Abstract][Full Text] [Related]
10. Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2. Soliman SSM; Hamoda AM; Nayak Y; Mostafa A; Hamdy R Eur J Med Chem; 2024 Oct; 276():116671. PubMed ID: 39004019 [TBL] [Abstract][Full Text] [Related]
11. Withanone from Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804 [TBL] [Abstract][Full Text] [Related]
12. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease. Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983 [TBL] [Abstract][Full Text] [Related]
13. Molecular modelling identification of phytocompounds from selected African botanicals as promising therapeutics against druggable human host cell targets of SARS-CoV-2. Uhomoibhi JO; Shode FO; Idowu KA; Sabiu S J Mol Graph Model; 2022 Jul; 114():108185. PubMed ID: 35430474 [TBL] [Abstract][Full Text] [Related]
14. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation. Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988 [TBL] [Abstract][Full Text] [Related]
15. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies. Azeem M; Mustafa G; Mahrosh HS Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies. Tatar G; Salmanli M; Dogru Y; Tuzuner T J Biomol Struct Dyn; 2022 Oct; 40(17):7656-7665. PubMed ID: 33749547 [TBL] [Abstract][Full Text] [Related]
17. Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19. Hui LY; Mun CS; Sing LC; Rajak H; Karunakaran R; Ravichandran V Med Chem; 2023; 19(3):297-309. PubMed ID: 35713125 [TBL] [Abstract][Full Text] [Related]
18. Metal-Bound Methisazone; Novel Drugs Targeting Prophylaxis and Treatment of SARS-CoV-2, a Molecular Docking Study. Abdelaal Ahmed Mahmoud M Alkhatip A; Georgakis M; Montero Valenzuela LR; Hamza M; Farag E; Hodgkinson J; Hosny H; Kamal AM; Wagih M; Naguib A; Yassin H; Algameel H; Elayashy M; Abdelhaq M; Younis MI; Mohamed H; Abdulshafi M; Elramely MA Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804129 [TBL] [Abstract][Full Text] [Related]
19. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2. Mishra A; Rathore AS Mol Divers; 2022 Oct; 26(5):2613-2629. PubMed ID: 35000060 [TBL] [Abstract][Full Text] [Related]
20. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases. Chowdhury T; Roymahapatra G; Mandal SM Infect Disord Drug Targets; 2021; 21(4):608-618. PubMed ID: 32718300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]